Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.

Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users.

Stein MD, Solomon DA, Herman DS, Anthony JL, Ramsey SE, Anderson BJ, Miller IW.

Arch Gen Psychiatry. 2004 Feb;61(2):152-9. Erratum in: Arch Gen Psychiatry. 2005 Feb;62(2):224.

PMID:
14757591
2.

Reductions in HIV risk behaviors among depressed drug injectors.

Stein MD, Anderson BJ, Solomon DA, Herman DS, Ramsey SE, Brown RA, Miller IW.

Am J Drug Alcohol Abuse. 2005;31(3):417-32.

PMID:
16161727
3.

Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users.

Stein MD, Solomon DA, Anderson BJ, Herman DS, Anthony JL, Brown RA, Ramsey SE, Miller IW.

Am J Addict. 2005 Jul-Sep;14(4):346-57.

PMID:
16188715
4.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
5.

Adherence to treatment of depression in active injection drug users: the minerva study.

Stein MD, Herman DS, Solomon DA, Anthony JL, Anderson BJ, Ramsey SE, Miller IW.

J Subst Abuse Treat. 2004 Mar;26(2):87-93.

PMID:
15050085
6.
7.

Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study.

Maina G, Rosso G, Crespi C, Bogetto F.

Psychother Psychosom. 2007;76(5):298-305.

PMID:
17700050
8.

A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.

Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR.

J Psychiatr Pract. 2005 Sep;11(5):302-14.

PMID:
16184071
9.

Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.

Van HL, Dekker J, Peen J, van Aalst G, Schoevers RA.

Psychother Psychosom. 2008;77(6):358-64. doi: 10.1159/000151389. Epub 2008 Aug 14.

PMID:
18701832
10.

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6.

PMID:
18344727
11.

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.

Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J.

J Affect Disord. 2002 Apr;68(2-3):317-30.

PMID:
12063159
12.

A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.

Ashman TA, Cantor JB, Gordon WA, Spielman L, Flanagan S, Ginsberg A, Engmann C, Egan M, Ambrose F, Greenwald B.

Arch Phys Med Rehabil. 2009 May;90(5):733-40. doi: 10.1016/j.apmr.2008.11.005.

PMID:
19406291
13.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
14.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
15.

[Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].

Spadone C, Sylvestre M, Chiarelli P, Richard-Berthe C.

Encephale. 2005 Nov-Dec;31(6 Pt 1):698-704. French.

PMID:
16462689
16.

Combining psychotherapy and antidepressants in the treatment of depression.

de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J.

J Affect Disord. 2001 May;64(2-3):217-29.

PMID:
11313088
17.

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M.

Health Technol Assess. 2007 Jul;11(24):1-54.

18.
19.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.

J Clin Psychiatry. 2005 Aug;66(8):1038-42.

PMID:
16086620
20.

Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?

Sultzer DL, Gray KF, Gunay I, Wheatley MV, Mahler ME.

J Am Geriatr Soc. 2001 Oct;49(10):1294-300.

PMID:
11890487

Supplemental Content

Support Center